Synthesis of a PCSK9 Inhibitor

Synfacts

doi 10.1055/s-0037-1609112

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

Georg Thieme Verlag KG

Related search

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Synthesis of a Glycine Transporter 1 Inhibitor

Synfacts
2012English

Gingival Ischemia and Petechiae in a Patient Medicated With PCSK9 Inhibitor for Hypercholesterolemia. An Adverse Drug Event?

Clinical advances in periodontics
Periodontics
2018English

Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2017English

A Therapeutic Peptide Vaccine Against PCSK9

Scientific Reports
Multidisciplinary
2017English

Synthesis of SMO Inhibitor PF-04449913

Synfacts
2014English

PCSK9 Peptide Inhibitors

Science-Business eXchange
2014English

Macarbomycin, an Inhibitor of Peptidoglycan Synthesis

Journal of Antibiotics
Drug DiscoveryPharmacology
1972English

Terpentecin, an Inhibitor of DNA Synthesis.

Journal of Antibiotics
Drug DiscoveryPharmacology
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy